Multimodal Therapy of Recurrent Severe Acute Disseminated Encephalomyelitis: The Role of Immunoadsorption

Key words

acute disseminated ­enzephalomyelitis - neuropediatrics - immunoadsorption - plasmapheresis

Schlüsselwörter

akute disseminierte ­Enzephalomyelitis - Neuropädiatrie - Immunadsorption - Plasmapherese

• References

• 1 Elhassanien AF, Aziz HA. Acute demyelinating encephalomyelitis: Clinical characteristics and outcome. J Pediatr Neurosci 2013; 8: 26-30
• 2 Fernández Carbonell C, Chitnis T. Inflammatory demyelinating diseases in children: an update. Minerva Pediatr 2013; 65: 307-323
• 3 Greinacher A, Friesecke S, Abel P et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 2011; 378: 1166-1173
• 4 Klingel R, Heibges A, Fassbender C. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – perspectives for immunoadsorption. Atheroscler Suppl 2013; 14: 161-165
• 5 McDaneld LM, Fields JD, Bourdette DN et al. Immunomodulatory therapies in neurologic critical care. Neurocrit Care 2010; 12: 132-143
• 6 Pohl D, Tenembaum S. Treatment of acute disseminated encephalomyelitis. Curr Treat Options Neurol 2012; 14: 264-275